Biomea Fusion, Inc. (BMEA)
NASDAQ · Healthcare
Biomea Fusion, Inc. Revenue 2020–2025
Biomea Fusion, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biomea Fusion, Inc. revenue for the quarter ending March 31, 2026 was 0.
- Biomea Fusion, Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Biomea Fusion, Inc. annual revenue for 2025 was 0.
- Biomea Fusion, Inc. annual revenue for 2024 was 0.
- Biomea Fusion, Inc. annual revenue for 2023 was 0.
- Biomea Fusion, Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomea Fusion, Inc. (BMEA) — Frequently Asked Questions
Biomea Fusion, Inc. (BMEA) is a publicly traded US company. It has a market capitalization of $63M. Explore BMEA's stock price, financial statements, earnings history, margins and key ratios below.
What is Biomea Fusion, Inc.'s market cap?
Biomea Fusion, Inc. (BMEA) has a market capitalization of $63M.
What is the BMEA stock price?
BMEA trades at $1.20 (+4.35% on the day).
Is BMEA profitable?
In fiscal 2025, Biomea Fusion, Inc. reported net income of -$62M.